Literature DB >> 32115913

CX3CR1 contributes to streptozotocin-induced mechanical allodynia in the mouse spinal cord.

Cheng-Ming Ni1, Bing-Yu Ling2, Xiang Xu1, He-Ping Sun3, Hui Jin1, Yu-Qiu Zhang4, Hong Cao4, Lan Xu1.   

Abstract

Patients with diabetic peripheral neuropathy experience debilitating pain that significantly affects their quality of life (Abbott et al., 2011), by causing sleeping disorders, anxiety, and depression (Dermanovic Dobrota et al., 2014). The primary clinical manifestation of painful diabetic neuropathy (PDN) is mechanical hypersensitivity, also known as mechanical allodynia (MA) (Callaghan et al., 2012). MA's underlying mechanism remains poorly understood, and so far, based on symptomatic treatment, it has no effective therapy (Moore et al., 2014).

Entities:  

Keywords:  P2X7 receptor (P2X7R); Mechanical allodynia; Streptozotocin; Diabetic mice

Mesh:

Substances:

Year:  2020        PMID: 32115913      PMCID: PMC7076343          DOI: 10.1631/jzus.B1900439

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  29 in total

1.  Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage.

Authors:  T Nishikawa; D Edelstein; X L Du; S Yamagishi; T Matsumura; Y Kaneda; M A Yorek; D Beebe; P J Oates; H P Hammes; I Giardino; M Brownlee
Journal:  Nature       Date:  2000-04-13       Impact factor: 49.962

2.  Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain.

Authors:  Jill A Lindia; Erin McGowan; Nina Jochnowitz; Catherine Abbadie
Journal:  J Pain       Date:  2005-07       Impact factor: 5.820

Review 3.  Diabetic neuropathy: clinical manifestations and current treatments.

Authors:  Brian C Callaghan; Hsinlin T Cheng; Catherine L Stables; Andrea L Smith; Eva L Feldman
Journal:  Lancet Neurol       Date:  2012-05-16       Impact factor: 44.182

4.  Nitric oxide synthase activity and expression in experimental diabetic neuropathy.

Authors:  D W Zochodne; V M Verge; C Cheng; A Höke; C Jolley; K Thomsen; I Rubin; M Lauritzen
Journal:  J Neuropathol Exp Neurol       Date:  2000-09       Impact factor: 3.685

5.  High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells.

Authors:  T Inoguchi; P Li; F Umeda; H Y Yu; M Kakimoto; M Imamura; T Aoki; T Etoh; T Hashimoto; M Naruse; H Sano; H Utsumi; H Nawata
Journal:  Diabetes       Date:  2000-11       Impact factor: 9.461

6.  Fractalkine mediates inflammatory pain through activation of satellite glial cells.

Authors:  Guilherme R Souza; Jhimmy Talbot; Celina M Lotufo; Fernando Q Cunha; Thiago M Cunha; Sérgio H Ferreira
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-17       Impact factor: 11.205

Review 7.  Spinal glial activation contributes to pathological pain states.

Authors:  Hong Cao; Yu-Qiu Zhang
Journal:  Neurosci Biobehav Rev       Date:  2008-04-03       Impact factor: 8.989

Review 8.  Role of advanced glycation end products in diabetic neuropathy.

Authors:  Kazuhiro Sugimoto; Minoru Yasujima; Soroku Yagihashi
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

9.  The liberation of fractalkine in the dorsal horn requires microglial cathepsin S.

Authors:  Anna K Clark; Ping K Yip; Marzia Malcangio
Journal:  J Neurosci       Date:  2009-05-27       Impact factor: 6.167

10.  The impact of neuropathic pain and other comorbidities on the quality of life in patients with diabetes.

Authors:  Vesna Dermanovic Dobrota; Pero Hrabac; Dinko Skegro; Ranko Smiljanic; Savko Dobrota; Ingrid Prkacin; Neva Brkljacic; Kristijan Peros; Martina Tomic; Vesna Lukinovic-Skudar; Vanja Basic Kes
Journal:  Health Qual Life Outcomes       Date:  2014-12-03       Impact factor: 3.186

View more
  1 in total

Review 1.  Chemokines and Pain in the Trigeminal System.

Authors:  Oscar O Solis-Castro; Natalie Wong; Fiona M Boissonade
Journal:  Front Pain Res (Lausanne)       Date:  2021-07-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.